Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

brain stem glioma - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

brain stem glioma

MONDO:0002911

Also known as:brain stem neuroglial neoplasmbrain stem neuroglial tumorbrain stem neuroglial tumour

Find Clinical TrialsTrials

Overview

A neuroglial tumor that arises from the brain stem.

Treatments1 FDA approved

Clinical Trials8 registered · 3 recruiting

Diagnosis

Biomarker and diagnostic research for brain stem glioma has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

1 FDA-approved treatment is available for brain stem glioma, including CARMUSTINE (CARMUSTINE, approved 1977). An additional 1 compound holds orphan drug designation.

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

8 clinical trials registered, 3 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and medical devices. Pipeline includes 2 PHASE3, 1 PHASE2, 3 PHASE1. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT00840047](https://clinicaltrials.gov/study/NCT00840047)

Data assembled from 4 of 12 sources · Last updated Sep 17, 2026, 11:25 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→What are the benefits and potential side effects of CARMUSTINE for managing brain stem glioma?
→Are any of the 8 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Laboratory research	101	53%
New treatment approaches	35	18%
Research summaries	26	14%
Clinical study results	10	5%
Testing and diagnosis research	8	4%
Disease patterns and progression	7	4%
Patient case studies	2	1%
Other research	1	1%

Kisho

brain stem glioma

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

Questions for Your Care Team

Questions for Your Care Team

Orphan Drug Designations

Clinical Trials

Recent Publications

brain stem glioma

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Orphan Drug Designations

Clinical Trials

Recent Publications